Encapsulated FMT clinical trials

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

The PROMISE trial is testing a new capsule treatment for people with liver scarring (cirrhosis), particularly those whose condition is linked to alcohol or fatty liver disease. These capsules contain healthy gut bacteria from donors and aim to reduce serious infections.